Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026

Recent News Articles

February 24, 2016

The GenCure tissue donation program is following longstanding procedures set up to screen for mosquito-borne viruses, including Zika.

In the case of postmortem tissue donation, donors diagnosed with a Zika virus infection within the last six months will be ineligible.

Donors of umbilical cord blood and placentas will be asked if they have been diagnosed with a Zika virus infection during pregnancy, or lived in or traveled to a region of Zika transmission during pregnancy. They also will be asked if they had sex during pregnancy with a man diagnosed with a Zika virus infection, or who traveled to a Zika virus transmission area, or lived in one of those areas.

January 22, 2016

The organization that works in partnership with the GenCure Marrow Donor Program has launched a subsidiary to focus on cellular therapy.

The National Marrow Donor Program/Be The Match announced in a news release that it has formed Be The Match BioTherapies, which will focus on forming partnerships with organizations working on developing new cellular therapy treatments.

In the last 25 years, NMDP/Be The Match has facilitated 74,000 marrow and cord blood transplants, as part of therapies for blood and related disorders. Be The Match BioTherapies will use that experience to work with organizations developing and providing new cellular therapies.

December 30, 2015

A bill to fund two programs that support treatment derived from adult stem cells through 2020 has been approved by Congress and signed by President Barack Obama.

The Stem Cell Therapeutic and Research Reauthorization Act received bipartisan support in both houses. The measure funds the C.W. Bill Young Cell Transplantation Program for five years at $30 million annually, while the National Cord Blood Inventory is authorized at $23 million annually for a 5 year period.

December 4, 2015

For the second year in a row, BioBridge Global will be serving as an organizing sponsor of the World Stem Cell Summit. The 2015 summit is next week in Atlanta.

Executives from BBG will be participating in multiple sessions at the event, which is coordinated by the Genetic Policy Institute and runs Dec. 10-12. BioBridge Global was an organizing sponsor of the 2014 summit, which was in San Antonio.

BBG subsidiary QualTex Laboratories operates a major facility in the Atlanta metro area.

November 23, 2015

A bill has been introduced in the U.S. House of Representatives that would allow parents to use funds from a health savings account or flexible spending account to pay for the collection and storage of umbilical cord blood in a private bank.

Sponsored by U.S. Reps. Erik Paulsen (R-Minn.) and Ron Kind (D-Wis.), the Family Cord Blood Banking Act would allow use of pre-tax HSA or FSA funds to pay for the collection and storage of the stem cell-rich cord blood.

Cord blood banking currently is not an authorized expense for either of the accounts, which are designed to help pay for healthcare not covered by insurance.

“After the birth of a child, parents are often immediately faced with a decision of whether to have blood and tissue collected and stored in case of future illness,” Paulsen said.